Upregulation of MicroRNA-126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis via Its Target PIK3R2

Journal of Cellular Biochemistry

Volumn 116, Issue 8, 2015, Pages 1613-1623

  Meng, Qingyou ^a   Wang, Wenbin ^b   Yu, Xiaobin ^a   Li, Wendong ^a   Kong, Lingshang ^a   Qian, Aimin ^a   Li, Chenglong ^a   Li, Xiaoqiang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

EPCs; HOMING; MIGRATION; miR 126; THROMBUS RESOLUTION

Indexed keywords

LENTIVIRUS VECTOR; LUCIFERASE; MICRORNA 126; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT P85 BETA PROTEIN; PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MICRORNA; MIRN126 MICRORNA, RAT; PIK3R2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL HOMING; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; EX VIVO STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THROMBUS; UPREGULATION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ANIMAL; CELL MOTION; DISEASE MODEL; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VEIN THROMBOSIS;

3' UNTRANSLATED REGIONS; ANIMALS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; ENDOTHELIAL PROGENITOR CELLS; MALE; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; UP-REGULATION; VENOUS THROMBOSIS;

EID: 84935012772     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25115     Document Type: Article

References (38)

1. Asahara T, Isner JM,. 2002. Endothelial progenitor cells for vascular regeneration. J Hematother Stem Cell Res 11: 171-178.
2. Bartel DP,. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Chen JJ, Zhou SH,. 2011. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol J 18: 675-681.
4. Chi L, Li Y, Stehno-Bittel L, Gao J, Morrison DC, Stechschulte DJ, Dileepan KN,. 2001. Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. J Interferon Cytokine Res 21: 231-240.
5. Diaz JA, Obi AT, Myers DD, Jr, Wrobleski SK, Henke PK, Mackman N, Wakefield TW,. 2012. Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol 32: 556-562.
6. Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W,. 2008. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358: 2765-2775.
7. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D,. 2008. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284.
8. Heusschen R, van Gink M, Griffioen AW, Thijssen VL,. 2010. MicroRNAs in the tumor endothelium: Novel controls on the angioregulatory switchboard. Biochim Biophys Acta 1805: 87-96.
9. Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Lamping DL, Johri M, Ginsberg JS,. 2008. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 149: 698-707.
10. Kuhnert F, Mancuso MR, Hampton J, Stankunas K, Asano T, Chen CZ, Kuo CJ,. 2008. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135: 3989-3993.
11. Kwaan HC, Samama MM,. 2010. The significance of endothelial heterogeneity in thrombosis and hemostasis. Semin Thromb Hemost 36: 286-300.
12. Landskroner-Eiger S, Moneke I, Sessa WC,. 2013. miRNAs as modulators of angiogenesis. Cold Spring Harb Perspect Med 3: a006643.
13. Lei FR, Li XQ, Liu H, Zhu RD, Meng QY, Rong JJ,. 2012. Rapamycin and 3-methyladenine regulate apoptosis and autophagy in bone-derived endothelial progenitor cells. Chin Med J (Engl) 125: 4076-4082.
14. Li XQ, Meng QY, Wu HR,. 2007. Effects of bone marrow-derived endothelial progenitor cell transplantation on vein microenvironment in a rat model of chronic thrombosis. Chin Med J (Engl) 120: 2245-2249.
15. Li W, Wang H, Kuang CY, Zhu JK, Yu Y, Qin ZX, Liu J, Huang L,. 2012. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem 363: 135-145.
16. Meng QY, Li XQ, Yu XB, Lei FR, Jiang K, Li CY,. 2010. Transplantation of VEGF165-gene-transfected endothelial progenitor cells in the treatment of chronic venous thrombosis in rats. Chin Med J (Engl) 123: 471-477.
17. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ,. 2012. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol 53: 64-72.
18. Meng S, Cao J, Zhang X, Fan Y, Fang L, Wang C, Lv Z, Fu D, Li Y,. 2013. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS ONE 8: e68611.
19. Modarai B, Burnand KG, Sawyer B, Smith A,. 2005. Endothelial progenitor cells are recruited into resolving venous thrombi. Circulation 111: 2645-2653.
20. Moldovan NI, Asahara T,. 2003. Role of blood mononuclear cells in recanalization and vascularization of thrombi: Past, present, and future. Trends Cardiovasc Med 13: 265-269.
21. Mriouah J, Boura C, Thomassin M, Bastogne T, Dumas D, Faivre B, Barberi-Heyob M,. 2012. Tumor vascular responses to antivascular and antiangiogenic strategies: Looking for suitable models. Trends Biotechnol 30: 649-658.
22. Nosaka M, Ishida Y, Kimura A, Kondo T,. 2010. Immunohistochemical detection of MMP-2 and MMP-9 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation. Int J Legal Med 124: 439-444.
23. Renault MA, Losordo DW,. 2007. The matrix revolutions: Matrix metalloproteinase, vasculogenesis, and ischemic tissue repair. Circ Res 100: 749-750.
24. Shiota M, Kusakabe H, Izumi Y, Hikita Y, Nakao T, Funae Y, Miura K, Iwao H,. 2010. Heat shock cognate protein 70 is essential for Akt signaling in endothelial function. Arterioscler Thromb Vasc Biol 30: 491-497.
25. Smadja DM, Laurendeau I, Avignon C, Vidaud M, Aiach M, Gaussem P,. 2006. The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost 4: 2051-2058.
26. Smadja DM, Basire A, Amelot A, Conte A, Bieche I, Le Bonniec BF, Aiach M, Gaussem P,. 2008. Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells. J Cell Mol Med 12: 975-986.
27. Tongers J, Losordo DW, Landmesser U,. 2011. Stem and progenitor cell-based therapy in ischaemic heart disease: Promise, uncertainties, and challenges. Eur Heart J 32: 1197-1206.
28. Ueki K, Fruman DA, Yballe CM, Fasshauer M, Klein J, Asano T, Cantley LC, Kahn CR,. 2003. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem 278: 48453-48466.
29. Urbich C, Kuehbacher A, Dimmeler S,. 2008. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588.
30. van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, Baelde HJ, Monge M, Vos JB, de Boer HC, Quax PH, Rabelink TJ, van Zonneveld AJ,. 2009. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 13: 1577-1585.
31. Verma RP, Hansch C,. 2007. Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs. Bioorg Med Chem 15: 2223-2268.
32. Wakefield TW, Linn MJ, Henke PK, Kadell AM, Wilke CA, Wrobleski SK, Sarkar M, Burdick MD, Myers DD, Strieter RM,. 1999. Neovascularization during venous thrombosis organization: A preliminary study. J Vasc Surg 30: 885-892.
33. Wakefield TW, Myers DD, Henke PK,. 2008. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 28: 387-391.
34. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN,. 2008. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271.
35. Wassmann S, Werner N, Czech T, Nickenig G,. 2006. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 99: e74-e83.
36. Yan T, Liu Y, Cui K, Hu B, Wang F, Zou L,. 2013. MicroRNA-126 regulates EPCs function: Implications for a role of miR-126 in preeclampsia. J Cell Biochem 114: 2148-2159.
37. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS,. 2005. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: The role of angiogenic cytokines and matrix metalloproteinases. Circulation 112: 1618-1627.
38. Zhang J, Zhang Z, Zhang DY, Zhu J, Zhang T, Wang C,. 2013. microRNA 126 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt signalling pathway. PLoS ONE 8: e83294.